Form D · Biotechnology
Stimcell Energetics Inc.
Vancouver, A1 · CIK 0001493712
Offering snapshot reported May 9, 2025 · SEC filing
- Reported sold
- $15K Offering amount: $15K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $15K Reported outside-investor minimum
- First sale
- Apr 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 9, 2025 | Initial | $15,000 | No comparison | 1 | SEC filing |
| Mar 26, 2024 | Initial | $45,000 | No comparison | 2 | SEC filing |
| Aug 2, 2021 | Initial | $5,000 | No comparison | Not reported | SEC filing |
| Jul 8, 2021 | Initial | $4,999 | No comparison | Not reported | SEC filing |
| Nov 18, 2020 | Initial | $82,000 | No comparison | 6 | SEC filing |
| May 6, 2020 | Initial | $26,000 | No comparison | 1 | SEC filing |
| Feb 3, 2015 | Initial | $195,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-545640
The shares were issued on conversion of debt
Source: Form D, filed May 9, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Adams | Director |
| Jean M Arnett | Director, Executive |
| Joao (John) Da Costa | Director |
| Bradley Hargreaves | Director, Executive |
| David Jeffs | Director, Executive |
| Frank E Mcenulty | Director, Executive |
| Frank Mc Enulty | Director, Executive |
| John Sanderson | Executive |
| Yanika Silina | Executive |
| Yana Silina | Executive |
| Amir Vahabzadeh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
820 1130 Pender Street, West
Vancouver, A1, V6E 4A4
Vancouver, A1, V6E 4A4